C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 3/06 (2006.01) A61K 31/702 (2006.01) C07H 3/08 (2006.01) C08B 37/18 (2006.01)
Patent
CA 2674539
The present invention relates to the use of at least one compound of the formula (I) or (II), in which Ri is H and n is an integer from 2 to 10, in the preparation of a drug for treating diseases from the group comprising tumour, cancer, viral disease, bacterial disease, fungal disease, immune system disease, auto-immune disease or disease associated with a Pimmunostimulation deficiency in human beings and warm-blood animals. The invention also relates to new products having a mannose or mannitol termination as well as a method for preparing the same.
La présente invention porte sur l'utilisation d'au moins un composé de formule (I) ou (II) dans lesquelles R1 représente H et n est un entier de 2 à 10, pour la préparation d'un médicament destiné au traitement de maladies choisies dans le groupe consistant en tumeur, cancer, maladie virale, maladie bactérienne, maladie fongique, maladie du système immunitaire, maladie auto-immune ou maladie liée à une déficience de Pimmunostimulation, chez des êtres humains et animaux à sang chaud, elle porte également sur des produits nouveaux à terminaison mannose ou mannitol ainsi que sur leur procédé de préparation.
Descroix Karine
Ferrieres Vincent
Jamois Frank
Laurent Isabelle
Vetvicka Vaclav
Laboratoire de La Mer
Laboratoires Goemar
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Use of modified oligo-.beta.-(1,3)-glucanes for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of modified oligo-.beta.-(1,3)-glucanes for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of modified oligo-.beta.-(1,3)-glucanes for treating... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1627572